Prospective study of concomitant stereotaxic reirradiation and mitomycin with cetuximab for recurrent head and neck cancer.

被引:0
|
作者
Nathalie, Lemoine
Lefebvre, Gautier
Tresch, Emmanuelle
Degardin, Marian
Maillard, Sophie
Coche-Dequant, Bernard
Singier, Stephane
Mailliez, Audrey
Marliot, Guillaume
Sakji, Ilyes
Amela, Eric
Kotecki, Nuria
Penel, Nicolas
El Bedoui, Sophie
Julieron, Morbize
Lartigau, Eric
机构
[1] Hop La Louviere, Lille, France
[2] Ctr Oscar Lambret, F-59020 Lille, France
[3] Ctr Oscar Lambret, Wattignies, France
[4] Oscar Lambret Comprehens Canc Ctr, Lille, France
关键词
D O I
10.1200/jco.2015.33.15_suppl.e17024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e17024
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Metronomic chemotherapy in recurrent head and neck cancer.
    Mateen, Abdul
    Adil, Allah Rakha
    Maken, Rab Nawaz
    Khan, Shahbaz Ahmad
    Arif, Muhammad
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] Prognostic factors in patients with recurrent head and neck cancer treated with reirradiation
    Krstevska, V.
    Tolevska, C.
    Zafirova-Ivanova, B.
    Stojkovski, I.
    Crvenkova, S.
    JOURNAL OF BUON, 2008, 13 (03): : 369 - 376
  • [33] Patterns of Failure After SBRT Reirradiation for Recurrent Head and Neck Cancer
    Moreno, A. C.
    Wang, X. A.
    Mohamed, A. S.
    Wang, H.
    Wang, C.
    Tung, S.
    Yang, J.
    Reddy, J.
    Lee, A.
    Spiotto, M.
    Fuller, C. D.
    Gunn, G. B.
    Frank, S. J.
    Rosenthal, D. I.
    Morrison, W. H.
    Garden, A. S.
    Phan, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E374 - E375
  • [34] FRACTIONATED STEREOTACTIC RADIOTHERAPY AS REIRRADIATION FOR LOCALLY RECURRENT HEAD AND NECK CANCER
    Roh, Kwang-Won
    Jang, Ji-Sun
    Kim, Min-Sik
    Sun, Dong-Il
    Kim, Bum-Soo
    Jung, So-Lyoung
    Kang, Jin-Hyoung
    Yoo, Eun-Jung
    Yoon, Sei-Chul
    Jang, Hong-Seok
    Chung, Su-Mi
    Kim, Yeon-Sil
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (05): : 1348 - 1355
  • [35] Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer
    Bauman, Julie E.
    Ohr, James
    Gooding, William E.
    Ferris, Robert L.
    Duvvuri, Umamaheswar
    Kim, Seungwon
    Johnson, Jonas T.
    Soloff, Adam C.
    Wallweber, Gerald
    Winslow, John
    Gaither-Davis, Autumn
    Grandis, Jennifer R.
    Stabile, Laura P.
    CANCERS, 2020, 12 (06) : 1 - 17
  • [36] Predicting Outcomes after Salvage Reirradiation of Recurrent Head and Neck Cancer
    Sircar, M.
    Koutcher, L.
    Wolden, S.
    Chou, J.
    Zhang, Z.
    Sherman, E.
    Wong, R.
    Kraus, D.
    Pfister, D.
    Lee, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S441 - S441
  • [37] Reirradiation of Recurrent and Second Primary Head and Neck Cancer With Proton Therapy
    McDonald, M. W.
    Zolali-Meybodi, O.
    Lehnert, S. J.
    Cohen-Gadol, A. A.
    Moore, M. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (04): : 930 - 931
  • [38] Reirradiation of Recurrent and Second Primary Head and Neck Cancer With Proton Therapy
    McDonald, Mark W.
    Zolali-Meybodi, Omid
    Lehnert, Stephen J.
    Estabrook, Neil C.
    Liu, Yuan
    Cohen-Gadol, Aaron A.
    Moore, Michael G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (04): : 808 - 819
  • [39] CONCOMITANT RADIOTHERAPY AND CETUXIMAB FOR HEAD AND NECK CANCER: LATE TOXICITY AND OUTCOMES
    Caparrotti, F.
    Vinh-Hung, V.
    Mach, N.
    Dulguerov, P.
    Miralbell, R.
    Betz, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (08) : 536 - 536
  • [40] The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer
    Tejani, Mohamedtaki A.
    Cohen, Roger B.
    Mehra, Ranee
    BIOLOGICS-TARGETS & THERAPY, 2010, 4 : 173 - 185